'Cell-based, innovative products for a better future'

Pluristem’s proprietary cell-based technology platform develops cutting-edge therapies and cultured food materials

Related Keywords

Israel ,Singapore ,Tel Aviv ,Yaky Yanay ,Haifa Technion ,Weizmann Institute Of Science ,Health Ministry ,Nasdaq ,Eu European Medicines Agency ,Israel Innovation Authority ,Tel Aviv Stock Exchange ,Us Department Of Defense ,Israel Institute Of Technology ,Tnuva Group ,European Investment Bank ,President Yaky ,Rami Zerenger ,Medicines Agency ,European Horizon ,Weizmann Institute ,Technion Israel Institute ,Acute Respiratory Distress Syndrome ,Hematopoietic Cell ,Acute Radiation ,Far East ,